Millennium Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9M | Buy |
965,967
+803,217
| +494% | +$9.05M | 0.01% | 1554 |
|
|
2025
Q1 | $1.64M | Buy |
+162,750
| New | +$1.64M | ﹤0.01% | 2719 |
|
|
2024
Q3 | – | Sell |
-184,343
| Closed | -$1.95M | – | 4398 |
|
|
2024
Q2 | $1.95M | Sell |
184,343
-203,719
| -52% | -$2.15M | ﹤0.01% | 2498 |
|
|
2024
Q1 | $4.09M | Sell |
388,062
-721,117
| -65% | -$7.6M | ﹤0.01% | 2129 |
|
|
2023
Q4 | $12.5M | Sell |
1,109,179
-1,126,442
| -50% | -$12.6M | 0.01% | 1324 |
|
|
2023
Q3 | $26.1M | Buy |
2,235,621
+539,645
| +32% | +$6.3M | 0.01% | 807 |
|
|
2023
Q2 | $17.1M | Buy |
1,695,976
+1,287,479
| +315% | +$13M | 0.01% | 1093 |
|
|
2023
Q1 | $3.02M | Buy |
408,497
+345,606
| +550% | +$2.55M | ﹤0.01% | 2247 |
|
|
2022
Q4 | $502K | Sell |
62,891
-20,797
| -25% | -$166K | ﹤0.01% | 3625 |
|
|
2022
Q3 | $269K | Buy |
+83,688
| New | +$269K | ﹤0.01% | 4267 |
|
|
2022
Q2 | – | Sell |
-140,186
| Closed | -$693K | – | 5513 |
|
|
2022
Q1 | $693K | Buy |
+140,186
| New | +$693K | ﹤0.01% | 3856 |
|